Bruker Stock Forecast, Price & News

Bruker's stock was trading at $40.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BRKR shares have increased by 6.4% and is now trading at $42.54.
View which stocks have been most impacted by COVID-19.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating, 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Bruker.

Bruker is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Bruker.

Bruker will be holding an earnings conference call on Monday, November 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Bruker Co. (NASDAQ:BRKR) posted its earnings results on Monday, August, 3rd. The medical research company reported $0.21 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.05 by $0.16. The medical research company had revenue of $424.60 million for the quarter, compared to analysts' expectations of $395.51 million. Bruker had a return on equity of 22.70% and a net margin of 8.35%. The business's revenue for the quarter was down 13.4% compared to the same quarter last year. During the same period last year, the company posted $0.33 earnings per share.
View Bruker's earnings history.

Bruker announced a quarterly dividend on Friday, August 7th. Stockholders of record on Tuesday, September 1st will be paid a dividend of $0.04 per share on Friday, September 18th. This represents a $0.16 annualized dividend and a yield of 0.38%. The ex-dividend date is Monday, August 31st.
View Bruker's dividend history.

10 analysts have issued 1 year price targets for Bruker's shares. Their forecasts range from $27.00 to $63.00. On average, they anticipate Bruker's stock price to reach $44.95 in the next twelve months. This suggests a possible upside of 5.7% from the stock's current price.
View analysts' price targets for Bruker.

Bruker saw a decline in short interest in October. As of October 15th, there was short interest totaling 2,490,000 shares, a decline of 19.2% from the September 30th total of 3,080,000 shares. Based on an average trading volume of 467,900 shares, the days-to-cover ratio is presently 5.3 days. Approximately 2.5% of the shares of the stock are short sold.
View Bruker's Short Interest.

Some companies that are related to Bruker include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Waters (WAT), Charles River Laboratories International (CRL), BIO-TECHNE (TECH), Pacific Biosciences of California (PACB), Luminex (LMNX), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), The Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Bruker's stock is owned by many different institutional and retail investors. Top institutional investors include Boston Trust Walden Corp (0.39%), Scout Investments Inc. (0.15%), Assenagon Asset Management S.A. (0.14%), Cambiar Investors LLC (0.11%), CWM LLC (0.10%) and State of New Jersey Common Pension Fund D (0.06%). Company insiders that own Bruker stock include Burkhard Prause, Cynthia M Friend, Frank H Laukien, Marc A Kastner and Mark Munch.
View institutional ownership trends for Bruker.

BRKR stock was sold by a variety of institutional investors in the last quarter, including BNP Paribas Arbitrage SA, WINTON GROUP Ltd, CWM LLC, Scout Investments Inc., Lipe & Dalton, and Comerica Bank. Company insiders that have sold Bruker company stock in the last year include Cynthia M Friend, and Marc A Kastner.
View insider buying and selling activity for Bruker.

BRKR stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Dupont Capital Management Corp, Boston Trust Walden Corp, Nisa Investment Advisors LLC, Cambiar Investors LLC, State of New Jersey Common Pension Fund D, Cambridge Investment Research Advisors Inc., and Envestnet Asset Management Inc..
View insider buying and selling activity for Bruker.

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BRKR stock can currently be purchased for approximately $42.54.

Bruker has a market capitalization of $6.51 billion and generates $2.07 billion in revenue each year. The medical research company earns $197.20 million in net income (profit) each year or $1.57 on an earnings per share basis. Bruker employs 7,230 workers across the globe.

The official website for Bruker is www.bruker.com.

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at (978) 663-3660 or via email at [email protected]